BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26439805)

  • 1. Targeting the Wnt signaling pathway in colorectal cancer.
    Sawa M; Masuda M; Yamada T
    Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
    Masuda M; Sawa M; Yamada T
    Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of TNIK inhibitors in cancer therapeutics.
    Yamada T; Masuda M
    Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNIK inhibition abrogates colorectal cancer stemness.
    Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
    Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Insight into TNIK Inhibition.
    Kukimoto-Niino M; Shirouzu M; Yamada T
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
    Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
    Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
    Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
    Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
    Lee Y; Jung JI; Park KY; Kim SA; Kim J
    Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
    Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
    Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of TNIK as a therapeutic target for colorectal cancer.
    Masuda M; Yamada T
    Expert Opin Ther Targets; 2017 Apr; 21(4):353-355. PubMed ID: 28281900
    [No Abstract]   [Full Text] [Related]  

  • 12. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.
    Phull MS; Jadav SS; Gundla R; Mainkar PS
    Eur J Med Chem; 2021 Feb; 212():113149. PubMed ID: 33445154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
    Park DS; Seo JH; Hong M; Choi SC
    Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasticity of WNT signaling activity in colorectal cancer].
    Horst D
    Pathologe; 2012 Nov; 33 Suppl 2():194-7. PubMed ID: 22968731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
    Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
    Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliotoxin Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells.
    Chen J; Wang C; Lan W; Huang C; Lin M; Wang Z; Liang W; Iwamoto A; Yang X; Liu H
    Mar Drugs; 2015 Oct; 13(10):6259-73. PubMed ID: 26445050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNIK influence the effects of antipsychotics on Wnt/β-catenin signaling pathway.
    Yuan R; Li Y; Fu Y; Ning A; Wang D; Zhang R; Yu S; Xu Q
    Psychopharmacology (Berl); 2021 Nov; 238(11):3283-3292. PubMed ID: 34350475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.